Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The study is designed as a single-center, prospective, interventional, non-pharmacological, randomized, open-label, controlled trial with parallel groups. It targets patients with prostate cancer or kidney cancer who are candidates for robot-assisted surgical treatment, specifically radical prostatectomy (RP) or partial nephrectomy (PN).
Epistemonikos ID: 1bdd2fbb7eb79e37803e40d86c0fef5922242305
First added on: Mar 27, 2025